Treatment of Skin Reaction Induced by Nivolumab Combined with Radiotherapy in Non-small Cell Lung Cancer: A Case Report
We reported a patient with advanced squamous cell lung cancer who suffered from serious skin immune-related adverse events when he was treated with nivolumab and radiotherapy. The immune overreaction of the treatment of anti-PD-1 treatment and radiotherapy might cause these serious skin adverse events. Our report warranted careful workup to reduce the risk of side effects by combinative therapy with anti-PD-1 and radiotherapy.
Source: Chinese Medical Sciences Journal - Category: General Medicine Source Type: research
More News: Brain | Cancer | Cancer & Oncology | China Health | Dermatology | General Medicine | Immunotherapy | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Psoriasis | Skin | Squamous Cell Carcinoma | Study | Toxicology | Vitiligo